Ifg Advisory, LLC Vertex Pharmaceuticals Inc Transaction History

Ifg Advisory, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$392.81 - $485.53 $856,718 - $1.06 Million	2,181 New	2,181 $1.02 Million
Q4 2023 Jan 17, 2024	BUY	$343.0 - $410.68 $4,802 - $5,749	14 Added 0.61%	2,319 $943,000
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $779,504 - $835,470	2,305 New	2,305 $801,000
Q1 2023 Apr 26, 2023	SELL	$283.23 - $323.1 $5,664 - $6,462	-20 Reduced 0.85%	2,342 $737,000
Q4 2022 Jan 31, 2023	BUY	$285.76 - $321.48 $8,287 - $9,322	29 Added 1.24%	2,362 $682,000
Q3 2022 Oct 28, 2022	BUY	$273.83 - $305.53 $638,845 - $712,801	2,333 New	2,333 $675,000
Q3 2019 Nov 06, 2019	SELL	$166.23 - $187.09 $376,344 - $423,571	-2,264 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$164.61 - $190.37 $7,736 - $8,947	47 Added 2.12%	2,264 $415,000
Q1 2019 May 08, 2019	SELL	$163.73 - $194.7 $25,869 - $30,762	-158 Reduced 6.65%	2,217 $407,000
Q4 2018 Feb 07, 2019	BUY	$151.91 - $192.21 $303 - $384	2 Added 0.08%	2,375 $393,000
Q3 2018 Nov 05, 2018	SELL	$167.73 - $192.74 $2,012 - $2,312	-12 Reduced 0.5%	2,373 $457,000
Q2 2018 Aug 02, 2018	BUY	$145.72 - $169.96 $20,692 - $24,134	142 Added 6.33%	2,385 $405,000
Q1 2018 Apr 26, 2018	SELL	$151.6 - $177.13 $758 - $885	-5 Reduced 0.22%	2,243 $0
Q4 2017 Feb 01, 2018	SELL	$137.28 - $155.55 $5.08 Million - $5.75 Million	-36,988 Reduced 94.27%	2,248 $336,000
Q4 2017 Jan 29, 2018	BUY	$137.28 - $155.55 $5.39 Million - $6.1 Million	39,236	39,236 $353,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Ifg Advisory, LLC with notifications on news.